📉 The Financial Deep Dive
Fabtech Technologies Limited's (NSE: FABTECH, BSE: 543345) third-quarter (ended December 31, 2025) financial results reveal significant year-on-year (YoY) performance deterioration, starkly contrasting with growth in the nine-month period.
The Numbers:
- Consolidated Q3 FY26: Revenue from operations declined by a substantial 39.6% YoY to ₹6,275.99 Lakhs (₹62.76 Cr) from ₹10,431.54 Lakhs in Q3 FY25. This revenue contraction led to a consolidated net loss attributable to owners of ₹567.79 Lakhs (₹5.68 Cr), a sharp reversal from a profit of ₹2,045.74 Lakhs (₹20.46 Cr) in the corresponding prior year quarter. Basic and Diluted EPS plummeted to (₹1.56) from ₹6.32 YoY.
- Consolidated Nine Months FY26: Despite the quarterly slump, revenue for the nine months ended December 31, 2025, grew 13.3% YoY to ₹25,224.74 Lakhs (₹252.25 Cr). However, net profit attributable to owners saw a 48.0% YoY decline to ₹1,630.23 Lakhs (₹16.30 Cr). An exceptional item of ₹177.49 Lakhs (profit from sale of LLP subsidiary stake) was recorded in this period.
- Standalone Q3 FY26: Revenue decreased 26.3% YoY to ₹4,715.79 Lakhs (₹47.16 Cr). The standalone net profit attributable to owners fell to ₹148.78 Lakhs (₹1.49 Cr) from ₹605.16 Lakhs (₹6.05 Cr) YoY. Basic and Diluted EPS was ₹0.41, down from ₹1.87 YoY.
- Standalone Nine Months FY26: Revenue increased 13.3% YoY to ₹15,785.04 Lakhs (₹157.85 Cr). Net profit, however, declined 47.7% YoY to ₹1,370.52 Lakhs (₹13.71 Cr). This decline is significant given that the prior year's nine-month standalone results included an exceptional gain of ₹2,197.80 Lakhs (₹21.98 Cr) from the sale of an associate stake, which was not present in the current period's comparison.
The Quality & IPO Proceeds:
The company is actively utilizing its Initial Public Offering (IPO) proceeds. As of December 31, 2025, ₹2,350.25 Lakhs (₹23.50 Cr) of IPO funds had been deployed, with a substantial ₹20,679.40 Lakhs (₹206.79 Cr) remaining available for working capital and general corporate purposes.
The Grill:
Management provided no specific forward-looking guidance or outlook for future quarters, leaving analysts and investors to decipher the company's trajectory based on the current performance. The significant YoY decline in Q3 consolidated revenue and profitability, despite 9-month revenue growth, raises questions about demand sustainability and cost management.
🚩 Risks & Outlook:
The absence of forward guidance is a primary concern. Investors will closely monitor the company's ability to reverse the quarterly trend and the effective deployment of the substantial unutilized IPO proceeds. Execution risks associated with the newly incorporated foreign subsidiary in Saudi Arabia (Fabtech Lifecare Company) for geographical expansion also warrant attention. The dissolution of the Risk Management Committee, while stated to be due to SEBI regulations, might be viewed cautiously by some governance-focused investors, with oversight now falling to the Audit Committee and Board.
